Patent details
EP2205257 Title: LAG-3Ig (IMP321) dosage regimes for use in the treatment of cancer
Basic Information
- Publication number:
- EP2205257
- PCT Application Number:
- PCT/IB/2008/002653
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP088363338
- PCT Publication Number:
- WO/2009/044273
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- LAG-3Ig (IMP321) dosage regimes for use in the treatment of cancer
- French Title of Invention:
- Posologie de LAG-3Ig (IMP321) pour son utilisation dans le traitement du cancer
- German Title of Invention:
- LAG-3Ig (IMP321) Dosierungsanleitung zur Verwendung bei der Behandlung von Krebs
- SPC Number:
Dates
- Filing date:
- 03/10/2008
- Grant date:
- 11/09/2013
- EP Publication Date:
- 11/09/2013
- PCT Publication Date:
- 09/04/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/07/2010
- EP B1 Publication Date:
- 11/09/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 03/10/2013
- Expiration date:
- 03/10/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 03/10/2008
- Name:
- Immutep
- Address:
- Parc Club Orsay 2, Rue Jean Rostand, 91400 Orsay, France (FR)
Inventor
- Name:
- TRIEBEL Frédéric
- Address:
- France (FR)
Priority
- Priority Number:
- 07291214
- Priority Date:
- 05/10/2007
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 38/17;
| Filing date | Document type | Number of pages |
|---|